Stocks and Investing Stocks and Investing
Fri, October 4, 2024
Thu, October 3, 2024

Leland Gershell Initiated (BBIO) at Hold on, Oct 3rd, 2024


Published on 2024-10-28 14:38:21 - WOPRAI, Leland Gershell
  Print publication without navigation


Leland Gershell of Oppenheimer, Initiated "BridgeBio Pharma, Inc." (BBIO) at Hold on, Oct 3rd, 2024.

Leland has made no other calls on BBIO in the last 4 months.



There are 6 other peers that have a rating on BBIO. Out of the 6 peers that are also analyzing BBIO, 0 agree with Leland's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Leland


  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $43 on, Wednesday, October 2nd, 2024
  • Josh Schimmer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $70 on, Monday, September 16th, 2024
  • Geoff Meacham of "B of A Securities" Maintained at Strong Buy and Held Target at $42 on, Wednesday, September 11th, 2024
  • Biren Amin of "Piper Sandler" Initiated at Buy and Held Target at $46 on, Wednesday, September 4th, 2024
  • Cory Kasimov of "Evercore ISI Group" Maintained at Buy with Decreased Target to $45 on, Wednesday, August 7th, 2024
  • Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $43 on, Wednesday, August 7th, 2024

Contributing Sources